California plans to make its own insulin and sell it super-cheap. Really. An Arm and a Leg (podcast).

Profits of the largest pharmaceutical companies grow 41% in the pandemic. [Lucro das maiores farmacêuticas cresce 41% na pandemia]. Poder360.

Extended interview:

How Many Variants And Deaths Are We Willing To Accept, Before We Protect The Whole World? Forbes.

W.T.O. countries agree to a limited relaxing of patent protections on coronavirus vaccines. The New York Times.

Behind Pfizer's new not-for-profit deal on patented vaccines and drugs. Devex.

African clinical trial denied access to key COVID drug Paxlovid. Nature.

RAI (Radiotelevisione italiana, national Italian broadcaster). Report.

Paxlovid e Molnupiravir, pillola anti-Covid: il ricatto delle case farmaceutiche ai sistemi sanitari. [Paxlovid and Molnupiravir, anti-Covid pill: the blackmail of pharmaceutical companies to health systems]. Corriere della Sera.



Merck’s Covid-19 pill may be a game-changer, but questions are already being raised about cost. STAT.

Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What It Costs to Make. The Intercept.

Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines? The New York Times.

Covid pill makers accused of selling drug to US at 40 times what it costs to make despite govt funding. Independent.

Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill. Fortune India.

Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill. Health Policy Watch.

'Entirely unsurprising': Merck slammed for 4,000% markup of taxpayer-funded COVID-19 drug. Salon.

KNX In Depth, (live LA current affairs radio show).

Buyers clamor for Merck's COVID-19 antiviral molnupiravir, but pricing is already controversial. Fierce Pharma.

WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document. Reuters.



40+ progressive public sector organizations compiled a directory of suggested hires to the Biden Transition team. I was honored to be included with 12 other prescription drug policy leaders.


States are trying to cap the price of insulin. NBC. Pharmaceutical companies are pushing back.

La insulina podría ser más barata sin que las farmacéuticas pierdan ganancias, según studio. El espectador.

Elizabeth Warren’s 2020 healthcare campaign policy paper.




Why Insulin Defies The Normal Rules Of Economics And Keeps Getting More Expensive. WBUR, 2019.


Why would the government make its own drugs? New Statesman.

Biologics and Biosimilars: Background and Key Issues. Congressional Research Service.



Insulin prices could be much lower and drug makers would still make healthy profits. STAT.



EU starts investigation of Aspen's cancer drug pricing. PmLiVE.

Drugs firms are accused of putting cancer patients at risk over price hikes. The Guardian.

Cancer drugs price rise 'costing NHS millions'. BBC.

Price hikes for some generic cancer drugs in the UK have skyrocketed. STAT.

The drug rebellion fighting big pharma to save the NHS millions.